Synthetic biology

#CAR-T #DNA #Drug development #Drug discovery #Podcast #Synthetic biology

Podcast: Building on current drug discovery methods

This is the latest episode of the free DDW podcast, “Building on current drug discovery methods”. It covers two narrated article written for Volume 22, Issue 2 – Spring 2021 of DDW and read aloud by Megan Thomas. The articles are called “The new synthesis: How synthetic DNA technology is… Read More

#News #Trending News

#Drug design #Drug development #Immunology / Virology & Vaccines #mRNA #RNA #Synthetic biology

RNA: a coming-of-age technology for viral vaccines 

Listen to this article on the DDW Podcast: Dr Andy Lane, Commercial Director at The Native Antigen Company, discusses the development of a new generation of vaccine platforms that can be rapidly adapted to novel threats on-demand and at low cost.  Vaccines are one of the most effective healthcare interventions for reducing… Read More

#Business & Investment #Editor's Choice #Exclusive Content #News #Opinion

#ELRIG #Events #Synthetic biology

bit.bio announces line-up for ELRIG UK’s Drug Discovery 2021 

Human synthetic biology enterprise bit.bio will be exhibiting, hosting a workshop and presenting at ELRIG UK’s Drug Discovery 2021, held at ACC Liverpool from October 19-20, 2021.   The company will be exhibiting at booth B16/B9, where visitors are able to learn about bit.bio’s mature, functional human… Read More

#News

#Cell / tissue culture #Drug development #Synthetic biology

Synthetic cells could help study drug activity in living tissues

Scientists have created new artificial tissues that mimic some of the complex characteristics and abilities of living tissues, paving the way towards unprecedented advances in medicine, soft-robotics, and micro-engineering. The University of Bristol-led breakthrough, published in Advanced Materials, has reported the first way to produce centimetre-sized artificial tissues of any… Read More

#News

#Biologics / Biotechnology #Cell sequencing #DNA #Drug development #Drug discovery #Genome editing #Genome sequencing #Life sciences #Sequencing #Synthetic biology

The new synthesis: How synthetic DNA technology is changing drug discovery

Listen to this article on the DDW Podcast: Dr Tim Brears, CEO, Evonetix and Dr Raquel Sanches-Kuiper, Director of Biology, Evonetix explore applications of synthetic DNA in drug discovery and development, the benefits and limitations of current methods, and the opportunities offered by emerging DNA synthesis technologies. On 16 April 16,… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#Biomedical research #Drug discovery #iPSC #Synthetic biology

Sitting down with…bit.bio

bit.bio is a synthetic biology company working on producing every human cell type at scale, with the aim of transforming the research and medicine landscape. Farah Patell-Socha, PhD, VP Research Products tells Lu Rahman about some of the company’s groundbreaking work in this field and the benefits it is creating… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#CRISPR #Drug discovery #Liquid handling #Synthetic biology

Expert advice: maintaining lab flow throughout the pandemic

Lu Rahman talks to John Fuller, Product Manager–Drug Discovery, Beckman Coulter Life Sciences about the pandemic’s impact on this global organisation and its customers — and what to expect in 2021 and beyond. Not surprisingly, the emergence of the Covid-19 pandemic in 2020 caused hundreds, if not thousands of drug… Read More

#Exclusive Content #News #Opinion